India to United States: Acyclovir Export Trade Route
India has recorded 511 verified shipments of Acyclovir exported to United States, representing a combined trade value of $72.7M USD. This corridor is served by 24 active Indian exporters, with an average shipment value of $142.2K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 40% of total export value with 34 shipments worth $29.4M USD. On the buying side, TO THE ORDER OF is the largest importer in United States with $17.2M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, HETERO LABS LIMITED — together control 85% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Acyclovir corridor is one of India's established pharmaceutical export routes, with 511 shipments documented worth a combined $72.7M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 40% of all export value, reflecting the consolidated nature of India's acyclovir manufacturing sector.
Across 24 active suppliers, the average shipment value stands at $142.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 37 days port-to-port. The route has recorded an annual growth rate of 9.4%, placing it at rank #1 among India's top acyclovir export destinations globally.
On the import side, key buyers of Indian acyclovir in United States include TO THE ORDER OF, MYLAN PHARMACEUTICALS INC,, MYLAN PHARMACEUTICALS INC and 59 others. TO THE ORDER OF is the single largest importer with 101 shipments valued at $17.2M USD.
